Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease

Carl D Kirkwood1, Josef Wagner, Karen Boniface

  • 1Enteric Virus Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia. carl.kirkwood@mcri.edu.au

Abstract

Insights

Mycobacterium avium subspecies paratuberculosis (MAP) DNA was detected in pediatric Crohn's disease (CD) patients' gut biopsies and blood. This suggests MAP may play a role in early pediatric CD development.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pediatric Inflammatory Bowel Disease (IBD)

Background:

  • Mycobacterium avium subspecies paratuberculosis (MAP) is a suspected factor in inflammatory bowel disease (IBD).
  • Previous MAP prevalence studies in adults show inconsistencies, possibly due to clinical differences and assay specificity.
  • This study investigates MAP presence in children with suspected Crohn's disease (CD) and ulcerative colitis (UC) before treatment.

Purpose of the Study:

  • To determine the presence of MAP in pediatric patients with IBD symptoms.
  • To analyze MAP in gut biopsy tissue and peripheral blood mononuclear cells (PBMC) at initial diagnosis.
  • To explore the potential link between MAP and early-stage pediatric IBD.

Main Methods:

  • Collected mucosal biopsies and PBMC from 142 children (62 CD, 26 UC, 54 non-IBD).
  • Performed MAP-specific IS900 polymerase chain reaction (PCR) on all specimens.
  • Conducted conventional MAP culture on a subset of patients.

Main Results:

  • MAP DNA detected significantly more often in CD mucosal biopsies (39%) vs. non-IBD (15%).
  • MAP DNA found more frequently in PBMC from CD patients (16%) vs. non-IBD (0%).
  • Viable MAP cultured from 4/10 CD biopsies, but not from UC or non-IBD biopsies, nor any PBMC.

Conclusions:

  • MAP presence in gut tissue and blood suggests its potential involvement in early pediatric CD.
  • This study provides evidence for MAP's role in the initial development of Crohn's disease in children.
  • Further research is warranted to confirm MAP's etiological role in pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...